{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:06:00Z","timestamp":1760123160754},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.chest.2022.02.032","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T15:45:25Z","timestamp":1645890325000},"page":"385-393","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene"],"prefix":"10.1016","volume":"162","author":[{"given":"Davide","family":"Elia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Vasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Geginat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Abrignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Bulgheroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cassandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Pacheco-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy K.","family":"Steagall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Harari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.chest.2022.02.032_bib1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1183\/13993003.00412-2015","article-title":"The changing face of a rare disease: lymphangioleiomyomatosis","volume":"46","author":"Harari","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2022.02.032_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.12703\/P6-116","article-title":"Management of lymphangioleiomyomatosis","volume":"6","author":"Taveira-DaSilva","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"5","key":"10.1016\/j.chest.2022.02.032_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J\u00a0Nippon Med Sch"},{"issue":"1","key":"10.1016\/j.chest.2022.02.032_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/lrb.2009.0024","article-title":"The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis","volume":"8","author":"Taveira-DaSilva","year":"2010","journal-title":"Lymphat Res Biol"},{"issue":"2","key":"10.1016\/j.chest.2022.02.032_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/35101031","article-title":"Two genetic hits (more or less) to cancer","volume":"1","author":"Knudson","year":"2001","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.chest.2022.02.032_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"issue":"Pt 20","key":"10.1016\/j.chest.2022.02.032_bib7","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J\u00a0Cell Sci"},{"issue":"2","key":"10.1016\/j.chest.2022.02.032_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.chest.2022.02.032_bib9","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8 Pt 1","key":"10.1016\/j.chest.2022.02.032_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1164\/ajrccm.164.8.2104095","article-title":"Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis","volume":"164","author":"Yu","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"50","key":"10.1016\/j.chest.2022.02.032_bib11","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.chest.2022.02.032_bib12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201003-0489OC","article-title":"Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis","volume":"182","author":"Cai","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"10.1016\/j.chest.2022.02.032_bib13","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1158\/0008-5472.CAN-07-1356","article-title":"TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis","volume":"67","author":"Pacheco-Rodriguez","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.chest.2022.02.032_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5858\/arpa.2015-0246-RA","article-title":"Pulmonary Langerhans cell histiocytosis: an update from the pathologists\u2019 perspective","volume":"140","author":"Roden","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"145","key":"10.1016\/j.chest.2022.02.032_bib15","doi-asserted-by":"crossref","first-page":"170042","DOI":"10.1183\/16000617.0042-2017","article-title":"New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis","volume":"26","author":"Torre","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"11","key":"10.1016\/j.chest.2022.02.032_bib16","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.chest.2022.02.032_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathol-020712-163959","article-title":"Pathogenesis of Langerhans cell histiocytosis","volume":"8","author":"Badalian-Very","year":"2013","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.chest.2022.02.032_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","article-title":"BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases","volume":"38","author":"Roden","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.chest.2022.02.032_bib19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1183\/13993003.01677-2015","article-title":"Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis","volume":"47","author":"Mourah","year":"2016","journal-title":"Eur Respir J"},{"issue":"19","key":"10.1016\/j.chest.2022.02.032_bib20","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.chest.2022.02.032_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5603\/ARM.a2017.0046","article-title":"Pulmonary Langerhans\u2019 cell histiocytosis in adults","volume":"85","author":"Radzikowska","year":"2017","journal-title":"Adv Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2022.02.032_bib22","doi-asserted-by":"crossref","first-page":"1700521","DOI":"10.1183\/13993003.00521-2017","article-title":"BRAF and NRAS mutations in circulating Langerhans-like CD1a(+) cells in a patient with pulmonary Langerhans\u2019 cell histiocytosis","volume":"50","author":"Zhang","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2022.02.032_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2022.02.032_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1378\/chest.13-1071","article-title":"Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis","volume":"145","author":"Cai","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2022.02.032_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.chest.2019.03.040","article-title":"Circulating lymphangioleiomyomatosis tumor cells with loss of heterozygosity in the TSC2 gene show increased aldehyde dehydrogenase activity","volume":"156","author":"Pacheco-Rodriguez","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2022.02.032_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"Zoller","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.chest.2022.02.032_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fcell.2018.00097","article-title":"CD44\/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression","volume":"6","author":"Wang","year":"2018","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.chest.2022.02.032_bib28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201412-2170LE","article-title":"Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation","volume":"191","author":"Steagall","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2022.02.032_bib29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","article-title":"Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm","volume":"186","author":"McCormack","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2022.02.032_bib30","first-page":"105","article-title":"Tumor heterogeneity: causes and consequences","volume":"1805","author":"Marusyk","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.chest.2022.02.032_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"22","key":"10.1016\/j.chest.2022.02.032_bib32","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.chest.2022.02.032_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMoa012087","article-title":"Clinical outcomes of pulmonary Langerhans\u2019-cell histiocytosis in adults","volume":"346","author":"Vassallo","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2022.02.032_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.22247","article-title":"MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis","volume":"54","author":"Nelson","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.chest.2022.02.032_bib35","doi-asserted-by":"crossref","first-page":"1901190","DOI":"10.1183\/13993003.01190-2019","article-title":"Genetic landscape of adult Langerhans cell histiocytosis with lung involvement","volume":"55","author":"Jouenne","year":"2020","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2022.02.032_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00428-017-2185-0","article-title":"Assessment of BRAF(V600E) mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reaction","volume":"472","author":"Pierry","year":"2018","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.chest.2022.02.032_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12955","article-title":"Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease","volume":"69","author":"Kamionek","year":"2016","journal-title":"Histopathology"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222003981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222003981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:01:40Z","timestamp":1715130100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222003981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0012369222003981"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.02.032","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}